# Correction: Discovery of dibenzylbutane lignan LCA derivatives as potent anti-inflammatory agents

**Authors:** Zhen Wang, Juan Zhang, Conghao Gai, Jing Wang, Xiaobin Zhuo, Yan Song, Yan Zou, Peichao Zhang, Guige Hou, Qingguo Meng, Qingjie Zhao, Xiaoyun Chai

PMC · DOI: 10.1039/d4md90023e · 2024-06-17

## TL;DR

This paper corrects a previously published study on new anti-inflammatory compounds derived from lignan LCA.

## Contribution

The paper provides corrections to prior research on dibenzylbutane lignan LCA derivatives.

## Key findings

- The original study's findings on anti-inflammatory agents are being corrected.
- The corrections address errors in the previously published work.

## Abstract

Correction for ‘Discovery of dibenzylbutane lignan LCA derivatives as potent anti-inflammatory agents’ by Zhen Wang et al., RSC Med. Chem., 2024, https://doi.org/10.1039/d4md00053f.

## Full-text entities

- **Diseases:** inflammatory (MESH:D007249)

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11253846/full.md

---
Source: https://tomesphere.com/paper/PMC11253846